Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Attention Deficit Hyperactivity Disorder: Unique Considerations in Athletes.

Stewman CG, Liebman C, Fink L, Sandella B.

Sports Health. 2018 Jan/Feb;10(1):40-46. doi: 10.1177/1941738117742906. Epub 2017 Nov 16. Review.

PMID:
29144831
2.

Long-QT Syndrome and Therapy for Attention Deficit/Hyperactivity Disorder.

Zhang C, Kutyifa V, Moss AJ, McNitt S, Zareba W, Kaufman ES.

J Cardiovasc Electrophysiol. 2015 Oct;26(10):1039-44. doi: 10.1111/jce.12739. Epub 2015 Aug 6.

3.

Methylphenidate off-label use and safety.

Trenque T, Herlem E, Abou Taam M, Drame M.

Springerplus. 2014 Jun 7;3:286. doi: 10.1186/2193-1801-3-286. eCollection 2014.

4.

Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges.

Stevens JR, Wilens TE, Stern TA.

Prim Care Companion CNS Disord. 2013;15(2). pii: PCC.12f01472. doi: 10.4088/PCC.12f01472. Epub 2013 Mar 28. No abstract available.

5.
6.

ADHD drugs and serious cardiovascular events in children and young adults.

Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA.

N Engl J Med. 2011 Nov 17;365(20):1896-904. doi: 10.1056/NEJMoa1110212. Epub 2011 Nov 1.

7.

An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults.

Wilens TE, Morrison NR, Prince J.

Expert Rev Neurother. 2011 Oct;11(10):1443-65. doi: 10.1586/ern.11.137. Review.

8.

Health effects of energy drinks on children, adolescents, and young adults.

Seifert SM, Schaechter JL, Hershorin ER, Lipshultz SE.

Pediatrics. 2011 Mar;127(3):511-28. doi: 10.1542/peds.2009-3592. Epub 2011 Feb 14. Review. Erratum in: Pediatrics. 2016 May;137(5):null.

9.

Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences.

Brinkman WB, Epstein JN.

Patient Prefer Adherence. 2011 Jan 17;5:45-56. doi: 10.2147/PPA.S10647.

10.

Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.

Winhusen TM, Somoza EC, Brigham GS, Liu DS, Green CA, Covey LS, Croghan IT, Adler LA, Weiss RD, Leimberger JD, Lewis DF, Dorer EM.

J Clin Psychiatry. 2010 Dec;71(12):1680-8. doi: 10.4088/JCP.09m05089gry. Epub 2010 May 18.

11.

Adderall and cardiovascular risk: A therapeutic dilemma.

Sichilima T, Rieder MJ.

Paediatr Child Health. 2009 Mar;14(3):193-5. No abstract available.

12.

Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function.

Vitiello B.

Child Adolesc Psychiatr Clin N Am. 2008 Apr;17(2):459-74, xi. doi: 10.1016/j.chc.2007.11.010. Review.

Supplemental Content

Support Center